Prophylactic antibiotic use after cleft lip repair: Does it reduce complications, and is it necessary?
Journal of Plastic, Reconstructive & Aesthetic Surgery · 2026
DOI: 10.1016/j.bjps.2026.08.021 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Plastic, Reconstructive & Aesthetic Surgery, 2026. Verfasst von Aidin Gharavi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Mayo Clinic Alix School of Medicine, Rochester, MN, USA. Hauptthemen laut MEDLINE: Cleft Lip, Antibiotic Prophylaxis, Surgical Wound Infection, Anti-Bacterial Agents. Die Arbeit nennt 18 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Cleft lip repair (CLR) is one of the most common reconstructive surgeries performed for congenital conditions. Although perioperative surgical antibiotic prophylaxis (SAP) is commonly used, evidence supporting its benefit in CLR is limited. METHODS: We performed a retrospective cohort study using the 2021-2024 American College of Surgeons Pediatric SAP Data Files. Infants ≤12 months who underwent primary CLR were categorized into three groups: no SAP, SAP without postoperative continuation, and SAP with continued postoperative IV antibiotics. Primary outcomes were 30-day SSI and readmission, which was evaluated using Firth penalized logistic regression. A prespecified subanalysis was performed in patients who underwent bilateral CLR (BCLR). RESULTS: A total of 4,966 patients met the inclusion criteria: 475 (9.6%) received no SAP, 3,250 (65.4%) received SAP without continuation, and 1,241 (25.0%) received SAP with postoperative continuation. SAP was administered to 90.4% of the patients, the most commonly used SAP was cefazolin (87.2%). The overall SSI rate was 0.7%. On multivariable analysis, neither SAP without continuation (OR 0.69, 95% CI 0.27-2.19, p=0.49) nor SAP with continuation (OR 0.61, 95% CI 0.20-2.12, p=0.41) were associated with decreased SSI. SAP was also not associated with reduced readmissions or composite complications. In the BCLR subanalysis, both SAP groups were significantly associated with decreased odds of SSI (OR 0.19 and 0.17, respectively; both p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Mayo Clinic Alix School of Medicine, Rochester, MN, USA.
- Department of Surgery, Division of Plastic Surgery, Mayo Clinic, Rochester, MN, USA.
- Department of Anesthesiology, Mayo Clinic, Rochester, MN, USA.
- Division of Pediatric Otolaryngology, Department of Otorhinolaryngology-Head & Neck Surgery, Mayo Clinic, Rochester, MN, USA.
- Department of Surgery, Division of Plastic Surgery, Mayo Clinic, Rochester, MN, USA; Department of Pediatric and Adolescents Medicine, Mayo Clinic, Rochester, MN, USA. Electronic address: Gibreel.Waleed@mayo.edu.
Zitieren
APA
Gharavi, A., Wan, R., Haile, D., Garcia, J. C., Mardini, S., Cofer, S., Bite, U., & Gibreel, W. (2026). Prophylactic antibiotic use after cleft lip repair: Does it reduce complications, and is it necessary?. Journal of Plastic, Reconstructive & Aesthetic Surgery. https://doi.org/10.1016/j.bjps.2026.08.021
Vancouver
Gharavi A, Wan R, Haile D, Garcia JC, Mardini S, Cofer S, et al. Prophylactic antibiotic use after cleft lip repair: Does it reduce complications, and is it necessary?. Journal of Plastic, Reconstructive & Aesthetic Surgery. 2026. doi:10.1016/j.bjps.2026.08.021
BibTeX
@article{Gharavi2026,
author = {Gharavi, Aidin and Wan, Rou and Haile, Dawit and Garcia, Jose Castro and Mardini, Samir and Cofer, Shelagh and Bite, Uldis and Gibreel, Waleed},
title = {Prophylactic antibiotic use after cleft lip repair: Does it reduce complications, and is it necessary?},
journal = {Journal of Plastic, Reconstructive & Aesthetic Surgery},
year = {2026},
doi = {10.1016/j.bjps.2026.08.021}
}
EUVIMED